Form 4: Pfizer Executive Rady A. Johnson Reports Acquisition of Phantom Stock Units

Executive Vice President Rady A. Johnson reports acquiring phantom stock units in Pfizer through the company's Supplemental Savings Plan.

Summary

• Rady A. Johnson, an Executive Vice President at Pfizer Inc., filed a Form 4 on July 12, 2024, reporting a transaction.
• The transaction involved the acquisition of 3 phantom stock units at a price of $28.66 per unit on July 11, 2024.
• These units were acquired through the Pfizer Supplemental Savings Plan (SSP).
• Following the reported transaction, Johnson directly owns 8,987 phantom stock units.
• The phantom stock units are settled in cash upon separation from service and can be transferred to an alternative investment account at any time.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing, indicating a neutral sentiment.

Positives

• The acquisition of phantom stock units through the Supplemental Savings Plan aligns the executive's interests with the company's performance.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Stakeholder Impact

• The transaction provides transparency to shareholders regarding executive compensation and alignment of interests.

Key Dates